Product Information
FAMOTIDINE 40 MG/5 ML SUSP is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1305 per ML under NDC 27241024949. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application on Sep 18, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/5mL
Manufacturer
Ajanta Pharma USA Inc.NDC
27241024949
Classification
Generic
Dosage Form
FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA217529FDA Approved
9/18/2023
TE Code
AB
On Market Since
4/25/2022
Pharmacological Classes
Price Statistics
The NADAC for FAMOTIDINE 40 MG/5 ML SUSP has been published 142 times since Jan 17, 2024, and over the history we have for it it has declined 78.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1305 per ML |
|---|---|
| All-time high | $0.6220 (Mar 13, 2024) |
| All-time low | $0.1305 (Sep 23, 2026) |
| 52-week high | $0.2148 |
| 52-week low | $0.1305 |
| Median price | $0.2483 |
| Average price | $0.2965 |
| Largest weekly change | +39.5% (Aug 21, 2024) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Famotidine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMOTIDINE 40 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 40 MG/5 ML SUSP, manufactured by Ajanta Pharma USA Inc., is $0.1305 per ML (NDC 27241024949), effective Sep 30, 2026.
How has the price of FAMOTIDINE 40 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has declined 78.0%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for FAMOTIDINE 40 MG/5 ML SUSP?
Since Jan 17, 2024, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has ranged from a low of $0.1305 (Sep 23, 2026) to a high of $0.6220 (Mar 13, 2024), with a median of $0.2483 per ML.
Are there cheaper alternatives to FAMOTIDINE 40 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of FAMOTIDINE 40 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FAMOTIDINE 40 MG/5 ML SUSP?
FAMOTIDINE 40 MG/5 ML SUSP (NDC 27241024949) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.